Acute bronchodilator response has limited value in differentiating bronchial asthma from COPD

Journal of Asthma

Volumn 42, Issue 5, 2005, Pages 367-372

  Chhabra, Sunil K ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

Asthma; COPD; Reversibility; Salbutamol; Spirometry

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; SALBUTAMOL; THEOPHYLLINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPIROMETRY;

EID: 23344437308     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1081/JAS-200062992     Document Type: Article

References (25)

1. National Asthma Education and Prevention Program. Expert Panel Report-Guidelines for Diagnosis and Management of Asthma. Publication No. 97, Bethesda, MD: National Institutes of Health, 1997.
2. Global Strategy for Asthma Management and Prevention. NIH Publication No. 02-3659, Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute, Revised 2002.
3. Pennock BE, Rogers RM, McCaffree DR. Changes in measured spirometric indices-what is significant? Chest 1981; 80:97-99.
4. Report of American College of Chest Physicians Committee on Emphysema. Criteria for the assessment of reversibility in airways obstruction. Chest 1974; 65:552-553.
5. Kesten S, Rebuck A. Is the short-term response to inhaled beta-adrenergic agonist sensitive or specific for distinguishing between asthma and COPD. Chest 1994; 105:1042-1045.
6. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European Respiratory Society. Eur Respir J, Suppl 1993; 16:5-40.
7. American Thoracic Society. Medical section of the American Lung Association. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144:1202-1218.
8. Meslier N, Racineux JL, Six P, Loackhart A. Diagnostic value of reversibility of chronic airway obstruction to separate asthma from chronic bronchitis; a statistical approach. Eur Respir J 1989; 2:497-505.
9. Brand PLP, Quanjer PH, Postma DS, Kerstjens HA, Koeter GH, Dekhuijzen PN, Sluiter HJ. Interpretation of brorichodilator response in patients with obstructive airways disease. Thorax 1992; 47:429-436.
10. Boulet L, Turcotte H, Hudon C, Carrier G., Maltais F. Clinical, physiological and radiological features of asthma with incomplete reversibility of airflow obstruction compared to those of COPD. Can Respir J 1998; 5:270-277.
11. Nicklaus TM, Burgin WW, Taylor JR, Spirometric tests to diagnose suspected asthma. Am Rev Respir Dis 1969; 100:153-159.
12. Eliasson O, Degraff AC. The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Am Rev Respir Dis 1985; 132:858-864.
13. Chhabra SK, Bhatnagar S. Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease. Indian J Chest Dis Allied Sci 2002; 44:91-97.
14. Girard WM, Light RW. Should the FVC be considered in evaluating response to bronchodilators? Chest 1983; 84:87-89.
15. Chhabra SK. FVC response in bronchoreversibility test. Indian J Chest Dis Allied Sci 2001; 43:9-11.
16. Chhabra SK, Vijayan VK, Gupta R, De S. Expression of bronchodilator response: comparison of four indices. Respir Med 2002; 96:611-614.
17. Pauwels RA, Buist SA, Calverley PMA, Jenkiris CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD). Workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276.
18. American Thoracic Society: 1994 update. Standardization of spirometry. Am J Respir Crit Care Med 1995; 152:1107-1136.
19. Jain SK, Gupta CK. Age, height and body weight as determinants of ventilatory norms in healthy men above forty years of age. Indian J Med Res 1967; 55:599-607.
20. Jain SK, Ramiah TJ. Spirometric studies in healthy men and women 15-40 years age. Indian J Chest Dis Allied Sci 1967; 9:1-8.
21. Ayres SM, Griesbach SJ, Reimold F, Evans RG. Bronchial component in chronic obstructive lung disease. Am J Med 1974; 57:183-191.
22. Ramsdell JW, Tisi GM. Determination of bronchodilatation in the clinical pulmonary function laboratory: role of changes in static lung volumes. Chest 1979; 76:622-628.
23. Pare PD, Lawson LM, Brooks LA. Patterns of response to inhaled bronchodilators in asthmatics. Am Rev Respir Dis 1983; 127:680-685.
24. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004; 59(suppl 1).
25. Sanchez-Toril F, Prieto L, Peris R, Perez JA, Millan M, Marin J. Differences in airway responsiveness to acetaldehyde and methacholine in asthma and chronic bronchitis. Eur Respir J 2000; 15:260-265.